Palisade Bio director receives RSU grants and shares
PALISADE BIO director Emil Chuang reported equity-based compensation and an RSU vesting.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PALISADE BIO director Emil Chuang reported equity-based compensation and an RSU vesting. On June 10, 2026, he exercised restricted stock units (RSUs) into 20,200 shares of common stock and received an additional grant covering 592,300 shares, both at a stated price of $0.00 per share.
The RSU grants are subject to service-based vesting. One grant vests in three equal annual installments starting on the earlier of the 2027 annual meeting of stockholders or the anniversary of June 10, 2026, contingent on continued service. Another RSU grant vested in full on June 10, 2026.
Insider Trade Summary
20,200 shares exercised/converted
Exercise
3 txns
Insider
Chuang Emil
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 20,200 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 592,300 | $0.00 | $0.00 |
| Exercise | Common Stock | 20,200 | $0.00 | $0.00 |
Holdings After Transaction:
Restricted Stock Units — 40,400 contracts (Direct);
Common Stock — 612,500 shares (Direct)
Footnotes (3)
- F1. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date.
- F2. The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026.
- F3. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date.
Key Figures
Common shares from RSU exercise: 20,200 shares
Compensation-related equity grant: 592,300 shares
RSU position after transactions: 40,400 RSUs
+3 more
6 metrics
Common shares from RSU exercise
20,200 shares
Common Stock acquired via RSU exercise on June 10, 2026
Compensation-related equity grant
592,300 shares
Common Stock reported as acquired on June 10, 2026 at $0.00
RSU position after transactions
40,400 RSUs
Restricted Stock Units reported following derivative transaction
Common shares after RSU exercise
612,500 shares
Total common stock reported following one June 10, 2026 transaction
Exercise price per RSU
$0.00 per share
Conversion or exercise price for 20,200 RSUs into common stock
RSU vesting schedule
3 equal annual installments
Service-based vesting beginning around 2027 stockholder meeting or June 10, 2026 anniversary
Key Terms
Restricted Stock Units, service-based vesting requirement, annual meeting of stockholders, derivative security, +1 more
5 terms
Restricted Stock Units financial
"The Reporting Person was granted restricted stock units ("RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
service-based vesting requirement financial
"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments"
annual meeting of stockholders financial
"the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026"
derivative security financial
"transaction_code_description": "Exercise or conversion of derivative security""
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did PALISADE BIO (PALI) director Emil Chuang report?
Emil Chuang reported acquiring equity through compensation-related awards. On June 10, 2026, he received a grant linked to 592,300 shares of common stock and exercised restricted stock units into 20,200 common shares, all at a stated transaction price of $0.00 per share.
What type of securities did Emil Chuang acquire in the latest PALISADE BIO Form 4?
He acquired PALISADE BIO common stock and restricted stock units. One transaction converted 20,200 RSUs into common shares, while another granted equity tied to 592,300 shares. These awards reflect non-cash, compensation-related acquisitions rather than open-market stock purchases or sales.
How do the PALISADE BIO RSUs granted to Emil Chuang vest over time?
The RSUs are subject to service-based vesting. One grant vests in three equal annual installments, beginning on the earlier of the 2027 annual stockholder meeting or the anniversary of June 10, 2026, provided Emil Chuang maintains continuous service with PALISADE BIO through each vesting date.
What does the June 10, 2026 RSU vesting mean for PALISADE BIO director ownership?
On June 10, 2026, an RSU grant vested and converted into 20,200 common shares for Emil Chuang. This increased his directly held common stock through equity compensation, aligning part of his compensation with PALISADE BIO’s share performance rather than cash salary.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates